Vancomycin use for pediatric clostridium difficile infection is increasing and associated with specific patient characteristics

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4307-4313

  Schwenk, Hayden T ^a   Graham, Dionne A ^a   Sharma, Tanvi S ^a   Sandora, Thomas J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; DEHYDRATION; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD; TERTIARY HEALTH CARE; UNITED STATES;

EID: 84882402172     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00661-13     Document Type: Article

References (30)

1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 31:431-455.
2. Kim J, Smathers SA, Prasad P, Leckerman KH, Coffin S, Zaoutis T. 2008. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 122:1266-1270.
3. Nylund CM, Goudie A, Garza JM, Fairbrother G, Cohen MB. 2011. Clostridium difficile infection in hospitalized children in the United States. Arch. Pediatr. Adolesc. Med. 165:451-457.
4. Benson L, Song X, Campos J, Singh N. 2007. Changing epidemiology of Clostridium difficile-associated disease in children. Infect. Control Hosp. Epidemiol. 28:1233-1235.
5. Zilberberg MD, Tillotson GS, McDonald C. 2010. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg. Infect. Dis. 16:604-609.
6. Sammons JS, Toltzis P. 2013. Recent trends in the epidemiology and treatment of Clostridium difficile infection in children. Curr. Opin. Pediatr. 25:116-121.
7. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. 2007. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin. Infect. Dis. 45:302-307.
8. American Academy of Pediatrics Committee on Infectious Diseases. 2013. Clostridium difficile infection in infants and children. Pediatrics 131: 196-200.
9. Pediatric Health Information System. 26 June 2013, posting date. PHIS description when referenced as data source. Pediatric Health Information System, Children's Hospital Association. Overland Park, KS. https://extranet .chca.com/CHCAForums/PHIS/PHIS%20Research/Pages/default.aspx.
10. Larson HE, Barclay FE, Honour P, Hill ID. 1982. Epidemiology of Clostridium difficile in infants. J. Infect. Dis. 146:727-733.
11. Al-Jumaili IJ, Shibley M, Lishman AH, Record CO. 1984. Incidence and origin of Clostridium difficile in neonates. J. Clin. Microbiol. 19:77-78.
12. Tullus K, Aronsson B, Marcus S, Mollby R. 1989. Intestinal colonization with Clostridium difficile in infants up to 18 months of age. Eur. J. Clin. Microbiol. Infect. Dis. 8:390-393.
13. Tamma P, Sandora T. 2012. Clostridium difficile infection in children: current state and unanswered questions. J. Pediatr. Infect. Dis. Soc. 1:230-243.
14. Shaklee J, Zerr DM, Elward A, Newland J, Leckerman K, Asti L, Guth R, Bass J, Selvarangan R, Coffin S, Zaoutis T. 2011. Improving surveillance for pediatric Clostridium difficile infection: derivation and validation of an accurate case-finding tool. Pediatr. Infect. Dis. J. 30:e38-e40.
15. Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM, Koepsell TD. 2001. Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics 107:e99.
16. Prasad PA, Coffin SE, Leckerman KH, Walsh TJ, Zaoutis TE. 2008. Pediatric antifungal utilization: new drugs, new trends. Pediatr. Infect. Dis. J. 27:1083-1088.
17. Berry JG, Hall DE, Kuo DZ, Cohen E, Agrawal R, Feudtner C, Hall M, Kueser J, Kaplan W, Neff J. 2011. Hospital utilization and characteristics of patients experiencing recurrent readmissions within children's hospitals. JAMA 305:682-690.
18. U.S. Bureau of Labor Statistics. 2012, posting date. Consumer price index. U.S. Bureau of Labor Statistics, Washington, DC. http://www.bls .gov/cpi/#tables.
19. Kim J, Shaklee JF, Smathers S, Prasad P, Asti L, Zoltanski J, Dul M, Nerandzic M, Coffin SE, Toltzis P, Zaoutis T. 2012. Risk factors and outcomes associated with severe Clostridium difficile infection in children. Pediatr. Infect. Dis. J. 31:134-138.
20. Sandora TJ, Fung M, Flaherty K, Helsing L, Scanlon P, Potter-Bynoe G, Gidengil CA, Lee GM. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr. Infect. Dis. J. 30:580-584.
21. Gerber JS, Newland JG, Coffin SE, Hall M, Thurm C, Prasad PA, Feudtner C, Zaoutis TE. 2010. Variability in antibiotic use at children's hospitals. Pediatrics 126:1067-1073.
22. Rangel SJ, Fung M, Graham DA, Ma L, Nelson CP, Sandora TJ. 2011. Recent trends in the use of antibiotic prophylaxis in pediatric surgery. J. Pediatr. Surg. 46:366-371.
23. Zaoutis T, Localio AR, Leckerman K, Saddlemire S, Bertoch D, Keren R. 2009. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics 123: 636-642.
24. Brady PW, Conway PH, Goudie A. 2010. Length of intravenous antibiotic therapy and treatment failure in infants with urinary tract infections. Pediatrics 126:196-203.
25. Rodemann JF, Dubberke ER, Reske KA, Seo DA, Stone HCD. 2007. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 5:339-344.
26. Ananthakrishnan AN, McGinley EL, Binion DG. 2008. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 57:205-210.
27. Kelsen JR, Kim J, Latta D, Smathers S, McGowan KL, Zaoutis T, Mamula P, Baldassano RN. 2011. Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease. Inflamm. Bowel Dis. 17:50-55.
28. Ananthakrishnan AN, Guzman-Perez R, Gainer V, Cai T, Churchill S, Kohane I, Plenge RM, Murphy S. 2012. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease. Aliment Pharmacol. Ther. 35:789-795.
29. Tai E, Richardson LC, Townsend J, Howard E, McDonald LC. 2011. Clostridium difficile infection among children with cancer. Pediatr. Infect. Dis. J. 30:610-612.
30. Stewart DB, Yacoub E, Zhu J. 2012. Chemotherapy patients with Clostridium difficile colitis have outcomes similar to immunocompetent C. difficile patients. J. Gastrointest Surg. 16:1566-1572.